Emerging Ethical Issues in Pharmacogenomics
- 1 January 2002
- journal article
- review article
- Published by Springer Nature in American Journal of PharmacoGenomics
- Vol. 2 (4) , 273-281
- https://doi.org/10.2165/00129785-200202040-00007
Abstract
No abstract availableKeywords
This publication has 47 references indexed in Scilit:
- Orphan drug product regulation – United StatesInt. Journal of Clinical Pharmacology and Therapeutics, 2002
- Initial sequencing and analysis of the human genomeNature, 2001
- Pharmacological treatment of the ion transport defect in cystic fibrosisExpert Opinion on Investigational Drugs, 2001
- Pharmacogenetics and pharmacogenomics: why is this relevant to the clinical geneticist?Clinical Genetics, 1999
- Making Genomic Medicine a RealityAmerican Journal of Human Genetics, 1999
- Pharmacogenomics and diagnosticsNature Biotechnology, 1998
- Why pharmacogenomics? Why now?Nature Biotechnology, 1998
- Increased risk of venous thrombosis in oral-contraceptive users who are carriers of factor V Leiden mutationThe Lancet, 1994
- Primary care and the human genome project. Into the breachArchives of Family Medicine, 1993
- Physiciansʼ knowledge of genetics and genetic testsAcademic Medicine, 1993